Target intelligence / Profile preview

Ankyrin repeat domain-containing protein 37 (ANKRD37)

Target
ANKRD37
Molecular classification
Other (ankyrin repeat domain-containing protein; not a classical receptor, enzyme, transporter, ion channel, or transcription factor)
01

Overview

Ankyrin repeat domain-containing protein 37 (ANKRD37) is a protein strongly induced by hypoxic conditions in various cell types, functioning as a transcriptional target of the hypoxia-inducible factor 1 (HIF-1) signaling pathway. ANKRD37 is localized in the cytosol, mitochondrion, and nucleoplasm. It is consistently upregulated in response to physiological hypoxia, serving as a marker of cellular adaptation to low oxygen environments. In specific contexts such as the placenta and renal carcinoma, ANKRD37 modulates trophoblast invasion and participates in metabolic reprogramming associated with hypoxia. It interacts physically with the protein Fem1b, which can mediate its degradation and may be involved in differentiation processes. Despite its clear role in stress response pathways, no evidence supports the classification of ANKRD37 as a receptor, enzyme, or direct drug target.

Other names
LRP2BPhLrp2bpLrp2bpLow-density lipoprotein receptor-related protein 2-binding proteinankyrin repeat domain-containing protein 37low density lipoprotein receptor-related protein binding proteinlow-density lipoprotein receptor-related protein 2-binding protein
02

Mechanism of action

Not established, as there are no known drugs specifically targeting ANKRD37

03

Biological functions

Cellular adaptation to hypoxia (response to low oxygen via HIF-1 signaling)Regulation of cellular metabolismRegulation of cell differentiationRegulation of cell migration and invasion (notably in placental trophoblasts)Negative regulator of NF-κB pathway (in trophoblasts)Part of stress and metabolic response
04

Disease associations

Cancer (implicated in clear cell renal cell carcinoma via metabolic reprogramming)Preeclampsia (involved in trophoblast migration/invasion)Potentially Developmental dysplasia of the hip (association noted, functional role unclear)Other (general marker of hypoxia and metabolic stress)
05

Safety considerations

None reported (no direct targeting by drugs, not a classical therapeutic target)
06

Interacting drugs

None known or reported
07

Biomarkers

Hypoxia marker (transcriptional target of HIF-1; upregulated in low oxygen or ischemic environments)Marker in clear cell renal cell carcinoma and preeclampsia

Beyond the preview

Go deeper on Ankyrin repeat domain-containing protein 37 (ANKRD37).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat domain-containing protein 37 (ANKRD37).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call